DK0716689T3 - Fremgangsmåde til fremstilling og dyrkning af hæmatopoietiske forløberceller - Google Patents

Fremgangsmåde til fremstilling og dyrkning af hæmatopoietiske forløberceller

Info

Publication number
DK0716689T3
DK0716689T3 DK95925778T DK95925778T DK0716689T3 DK 0716689 T3 DK0716689 T3 DK 0716689T3 DK 95925778 T DK95925778 T DK 95925778T DK 95925778 T DK95925778 T DK 95925778T DK 0716689 T3 DK0716689 T3 DK 0716689T3
Authority
DK
Denmark
Prior art keywords
pct
progenitor cells
cultivation
preparation
hematopoietic progenitor
Prior art date
Application number
DK95925778T
Other languages
English (en)
Inventor
Hartmut Beug
Oliver Wessely
Eva Deiner
Lindern Maartje Marie Von
Peter Steinlein
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Application granted granted Critical
Publication of DK0716689T3 publication Critical patent/DK0716689T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0641—Erythrocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/148—Transforming growth factor alpha [TGF-a]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C12N2501/392—Sexual steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK95925778T 1994-06-30 1995-06-28 Fremgangsmåde til fremstilling og dyrkning af hæmatopoietiske forløberceller DK0716689T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4422667A DE4422667A1 (de) 1994-06-30 1994-06-30 Verfahren zur Herstellung und Züchtung hämatopoetischer Vorläuferzellen
PCT/EP1995/002516 WO1996000777A1 (de) 1994-06-30 1995-06-28 Verfahren zur herstellung und züchtung hämatopoetischer vorläuferzellen

Publications (1)

Publication Number Publication Date
DK0716689T3 true DK0716689T3 (da) 2003-01-27

Family

ID=6521750

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95925778T DK0716689T3 (da) 1994-06-30 1995-06-28 Fremgangsmåde til fremstilling og dyrkning af hæmatopoietiske forløberceller

Country Status (10)

Country Link
US (1) US5905041A (da)
EP (1) EP0716689B1 (da)
JP (1) JPH09502359A (da)
AT (1) ATE225396T1 (da)
CA (1) CA2170642A1 (da)
DE (2) DE4422667A1 (da)
DK (1) DK0716689T3 (da)
ES (1) ES2184805T3 (da)
PT (1) PT716689E (da)
WO (1) WO1996000777A1 (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2794473B1 (fr) * 1999-06-03 2003-09-26 Centre Nat Rech Scient Procede de multiplication de cellules souches
US6761883B2 (en) * 1999-06-29 2004-07-13 The Board Of Trustees Of The Leland Stanford Junior University Mammalian myeloid progenitor cell subsets
US6465247B1 (en) 1999-06-29 2002-10-15 The Board Of Trustees Of The Leland Stanford Junior University Mammalian myeloid progenitor cell subsets
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
ES2522890T3 (es) 2000-12-06 2014-11-19 Anthrogenesis Corporation Método para recolectar células troncales placentarias
NZ527849A (en) 2001-02-14 2006-09-29 Anthrogenesis Corp Post-partum mammalian placenta, its use and placental stem cells therefrom
EP1464698A4 (en) * 2001-12-13 2006-04-12 Japan Science & Tech Agency HUMAN CELL CULTURE MEDIUM AND CULTIVATION PROCESS
WO2004046312A2 (en) * 2002-11-15 2004-06-03 The Board Of Trustees Of The University Of Illinois Methods for in vitro expansion of hematopoietic stem cells
CA2505534A1 (en) 2002-11-26 2004-06-10 Anthrogenesis Corporation Cytotherapeutics, cytotherapeutic units and methods for treatments using them
EP1613742A2 (en) * 2003-04-08 2006-01-11 YEDA RESEARCH AND DEVELOPMENT Co. LTD. Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same
JP2007536935A (ja) 2004-05-14 2007-12-20 ベクトン・ディキンソン・アンド・カンパニー 間葉幹細胞の無血清増殖のための細胞培養環境
EP2626415A3 (en) 2004-10-25 2014-04-16 Cellerant Therapeutics, Inc. Methods of expanding myeloid cell populations and uses thereof
US8257696B2 (en) * 2004-11-19 2012-09-04 University Of Florida Research Foundation, Inc. Indefinite culture of human adult glia without immortalization and therapeutic uses thereof
DK1957633T3 (da) 2005-10-13 2014-03-17 Anthrogenesis Corp Immunomodulation under anvendelse af placentale stamceller
KR20190104428A (ko) 2005-12-29 2019-09-09 안트로제네시스 코포레이션 태반 줄기 세포 집단
JP2009521930A (ja) 2005-12-29 2009-06-11 アントフロゲネシス コーポレーション 胎盤幹細胞及び第２供給源由来幹細胞の共存培養
CA2677679A1 (en) * 2007-02-12 2008-08-21 Anthrogenesis Corporation Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations
SI2120977T1 (sl) 2007-02-12 2014-01-31 Anthrogenesis Coroporation Zdravljenje vnetnih bolezni z uporabo placentarnih matičnih celic
TWM322542U (en) * 2007-05-23 2007-11-21 Universal Scient Ind Co Ltd Testing machine
US9200253B1 (en) 2007-08-06 2015-12-01 Anthrogenesis Corporation Method of producing erythrocytes
WO2009045360A2 (en) 2007-09-28 2009-04-09 Celgene Cellular Therapeutics Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
US8828376B2 (en) * 2008-08-20 2014-09-09 Anthrogenesis Corporation Treatment of stroke using isolated placental cells
KR20240052847A (ko) 2008-08-20 2024-04-23 셀룰래리티 인코포레이티드 개선된 세포 조성물 및 그의 제조 방법
US8728805B2 (en) 2008-08-22 2014-05-20 Anthrogenesis Corporation Methods and compositions for treatment of bone defects with placental cell populations
RU2562154C2 (ru) 2008-11-19 2015-09-10 Антродженезис Корпорейшн Амниотические адгезивные клетки
EP3190179A1 (en) 2009-07-02 2017-07-12 Anthrogenesis Corporation Method of producing erythrocytes without feeder cells
EP3284818B1 (en) 2010-01-26 2022-03-09 Celularity Inc. Treatment of bone-related cancers using placental stem cells
US20130059783A1 (en) * 2010-03-12 2013-03-07 Johan Flygare Compositions and methods for expanding bfu-e cells
TW201902496A (zh) 2010-04-07 2019-01-16 美商安瑟吉納西斯公司 利用胎盤幹細胞之血管新生
AU2011237743A1 (en) 2010-04-08 2012-11-01 Anthrogenesis Corporation Treatment of sarcoidosis using placental stem cells
KR20190108599A (ko) 2010-07-13 2019-09-24 안트로제네시스 코포레이션 천연 킬러 세포의 생성 방법
US8969315B2 (en) 2010-12-31 2015-03-03 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory RNA molecules
CN113559126A (zh) 2011-06-01 2021-10-29 人类起源公司 利用胎盘干细胞治疗疼痛
WO2013055476A1 (en) 2011-09-09 2013-04-18 Anthrogenesis Corporation Treatment of amyotrophic lateral sclerosis using placental stem cells
CN115137753A (zh) 2013-02-05 2022-10-04 细胞结构公司 来自胎盘的自然杀伤细胞
WO2014186508A1 (en) 2013-05-15 2014-11-20 University Of Rechester Human extensively self-renewing erythroblasts (esre)
CN111349604B (zh) 2016-05-18 2023-12-12 学校法人庆应义塾 类器官培养用细胞培养基、培养方法及类器官

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399493A (en) * 1989-06-15 1995-03-21 The Regents Of The University Of Michigan Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
US5270458A (en) * 1991-04-02 1993-12-14 The Trustees Of Princeton University Nucleic acids encoding fragments of hematopoietic stem cell receptor flk-2
WO1993018136A1 (en) * 1992-03-05 1993-09-16 Cytomed, Inc. Process for supporting hematopoietic progenitor cells
AU4402193A (en) * 1992-06-08 1994-01-04 Becton Dickinson & Company Human primitive stem cells
AU5143393A (en) * 1992-10-02 1994-04-26 Systemix, Inc. Method of enrichment for human hematopoietic stem cells using c-kit
US5405772A (en) * 1993-06-18 1995-04-11 Amgen Inc. Medium for long-term proliferation and development of cells

Also Published As

Publication number Publication date
DE4422667A1 (de) 1996-01-04
ATE225396T1 (de) 2002-10-15
JPH09502359A (ja) 1997-03-11
ES2184805T3 (es) 2003-04-16
PT716689E (pt) 2003-02-28
US5905041A (en) 1999-05-18
CA2170642A1 (en) 1996-01-11
DE59510402D1 (de) 2002-11-07
WO1996000777A1 (de) 1996-01-11
EP0716689A1 (de) 1996-06-19
EP0716689B1 (de) 2002-10-02

Similar Documents

Publication Publication Date Title
DK0716689T3 (da) Fremgangsmåde til fremstilling og dyrkning af hæmatopoietiske forløberceller
EP0453453A4 (en) Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells
DE69535328D1 (de) In-vitro wachstum von langerhans'schen inseln und ihre verwendungen
EA199800835A1 (ru) Среда для культуры клеток млекопитающихся, способ ее получения и смесь компонентов, композиция, способы получения, продуцирования клонального роста, размножения и изменения фенотипа гепатоцитов in vitro, клетки, фармацевтический состав, способы получения рекомбинантной клетки и генного продукта, способы использования клеток, способ трансплантации гепатоцитов, способ испытания лекарственного препарата, способ поддержания жизнеспособности дифференцированных гепатоцитов
DE69531457D1 (en) Sulfonamide
DK0534955T3 (da) Fremgangsmåde til fremstilling af en zeaxanthinholdig sammensætning under anvendelse af en mikroorganisme af arten Flavobacterium multivorum.
FR2668063B1 (da)
DK0789588T3 (da) Metode til fremstilling af et medikament til behandling af sekundær immundefekt
DK0701604T3 (da) Immortalisering af dendritiske celler med V-myc-onkogenet
ES8402346A1 (es) Procedimiento para la obtencion de lineas de celulas animales y humanas cultivables permanentemente.
ATE24505T1 (de) Cyclohexan-1,3-dionderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses.
ES8307886A1 (es) "procedimiento para la fabricacion de combustibles para motores diesel".
MX9701087A (es) Procedimiento novedoso para la preparacion de diisopinoalcanforilcloroborano.
ES8504807A1 (es) Procedimiento para preparar nuevas 4-fenil-tetrahidrofurano (2, 3-c) piridinas
EP0765398A4 (en) POPULATION OF CELLS ENRICHED IN MYELOID AND / OR LYMPHOID PRECURSORS, PROCESSES FOR OBTAINING AND USING THE SAME
ATE205473T1 (de) Neue borneolderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
DK0804450T3 (da) Fremgangsmåde til fremstilling af palatinitol
MX9600735A (es) Procedimiento para la produccion y cultivo de celulas precursoras hematopoyeticas.
DK0485504T3 (da) Fremgangsmåde til fremstilling af aktiveret protein C ved celledyrkning
ATE211460T1 (de) Verfahren zur herstellung von substituierten anthrachinonen und deren verwendung zur herstellung von rheinen
ES2036219T3 (es) 2,2; 6,6-dietilen-3-oxo-17alfa-pren-4-en-21,17alfa-carbolactonas, procedimiento para su preparacion y preparados farmaceuticos que las contienen.
SU815035A1 (ru) Устройство дл культивировани фОллиКулОВ
Carpenter From the AACHT
Neuhart Peroxidase, protein, and growth responses of cultured tomato pith explants
ATE104266T1 (de) 1-brom-3-chlor-1,2-diaryl-2-propanole, verfahren zur stereoselektiven herstellung der erythro-1- brom-3-chlor-1,2-diaryl-2-propanole und deren umsetzung zu azolylmethyloxiranen.